Fact CheckerSign in

NCT05715255Active, not recruiting

Adaptive Symptom Self-Management Immunotherapy Study

Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

The use of immune checkpoint inhibitors (ICIs), alone or in combination with other cancer treatments is increasing dramatically with immune-related adverse events (irAEs) common (90%) during ICI treatment. Most irAEs are symptomatic and symptom self-management with timely reporting of moderate or severe symptoms to health care providers (HCPs) may reduce irAE severity by early recognition and management, resulting in fewer treatment interruptions and unscheduled health services.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
400 (estimated)
First submitted
27 Jan 2023
Start date
8 May 2023
Primary completion date
30 Apr 2027
Lead sponsor
University of Arizona
NCT number
NCT05715255

What you commit to

  • Study type: Interventional
  • Planned participants: 400
  • From 8 May 2023 to the primary completion date, 30 Apr 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently receiving regular behavioral counseling

Who the study is looking for

  • Age 18 or older
  • Within 12 weeks after starting ICI treatment for cancer
  • Cognitively oriented to person, place and time (determined by recruiter)
  • Able to speak and understand English or Spanish
  • Access to a telephone
  • Severity score of 1 (mild) or higher on at least 1 of the 3 indicators of psychological distress from the PRO-CTCAE (i.e., the three items of anxious, discouraged, sad) library

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status
Valleywise Health Medical Center
Coordinator of this site? Confirm its status
PhoenixUnited StatesUnknown status
University of Arizona Cancer Center
Coordinator of this site? Confirm its status
TucsonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.